Enter a US- or ASX-listed ticker (e.g. MU or BHP) to see shares that have behaved similarly in the market — and which tracked tipsters have called them, with how those calls scored. This is descriptive, factual information about share characteristics, not a recommendation to buy, sell or switch.
Signal: Blended · Business class · Price co-movement · how these are computed
| # | Ticker | Company | Sector / industry | Similarity | Tracked tipster calls |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Health Care · Pharmaceuticals | 55 | no tracked calls |
| 2 | ABT | Abbott Laboratories | Health Care · Diversified Health Care Equipment | 35 | no tracked calls |
| 3 | MRK | Merck & Company Inc | Health Care · Pharmaceutical Manufacturing | 33 | no tracked calls |
| 4 | PFE | Pfizer Inc | Health Care · Drug Manufacturers - General | 33 | no tracked calls |
| 5 | ABBV | AbbVie Inc | Health Care · Pharmaceutical Manufacturing | 29 | no tracked calls |
| 6 | GILD | Gilead Sciences Inc | Health Care · Pharmaceutical & Biotech | 29 | no tracked calls |
| 7 | ISRG | Intuitive Surgical Inc | Health Care · Surgical Robotics & Instruments | 29 | no tracked calls |
| 8 | VRTX | Vertex Pharmaceuticals Inc | Health Care · Biopharmaceutical Development & Manufacturing | 29 | no tracked calls |
| 9 | MDT | Medtronic PLC | Health Care · Medical Device Manufacturers | 28 | no tracked calls |
| 10 | REGN | Regeneron Pharmaceuticals Inc | Health Care · Biotechnology | 28 | no tracked calls |
| 11 | AMGN | Amgen Inc | Health Care · Biopharmaceuticals | 24 | no tracked calls |
| 12 | BMY | Bristol-Myers Squibb Company | Health Care · Pharmaceuticals | 24 | no tracked calls |
Similarity is a 0–100 index of how closely each company matches it by industry and business type (higher = more alike). The Tracked tipster calls column shows how many tracked public calls each peer has, from how many sources, and the best 90-day alpha among them — historical, measured outcomes (click a ticker to see who called it). How this is computed.
Hypothetical, paper-traded outcomes — entries are simulated at the first market bar after a call was detected; no real capital is at risk. Past performance is no guarantee of future results. This is general information about share characteristics, not a recommendation to buy, sell, or switch between any securities.